SCHEMBL16113191

SCHEMBL16113191

C1=CC(c2ncc3cc[nH]c3n2)CCN1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.32
AXL P30530 1/20 0.30
NUDT1 P36639 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4062743 0.79 AXL (0.32) APPAXLNUDT1
SCHEMBL25523073 0.72 ALOX5AP (0.41) AXLNUDT1
SCHEMBL5355503 0.72 JAK1 (0.42)
SCHEMBL30406662 0.72 ALOX5AP (0.41) AXLNUDT1
SCHEMBL5873715 0.68
SCHEMBL28298844 0.67 AXL (0.33) APPAXLNUDT1
SCHEMBL31251321 0.67 FAAH (0.36) AXLNUDT1
SCHEMBL8609416 0.66 TNKS (0.38) APP
SCHEMBL6674240 0.63 TYR (0.40)
SCHEMBL5336883 0.61 MEN1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2970299-A1 PYRROLOPYRIMINDINE CDK9 KINASE INHIBITORS Abbvie Inc. (US) 2016-01-20 EP claimed
WO-2014160028-A1 PYRROLOPYRIMINDINE CDK9 KINASE INHIBITORS ABBVIE INC. (US) 2014-10-02 WO claimed
EP-2970299-A1 PYRROLOPYRIMINDINE CDK9 KINASE INHIBITORS Abbvie Inc. (US) 2016-01-20 EP disclosed
WO-2014160028-A1 PYRROLOPYRIMINDINE CDK9 KINASE INHIBITORS ABBVIE INC. (US) 2014-10-02 WO disclosed